[Microbial etiology of bacterial chronic prostatitis: systematic review].

IF 1.9 4区 医学 Q4 MICROBIOLOGY Revista Espanola De Quimioterapia Pub Date : 2023-04-01 DOI:10.37201/req/099.2022
R Mendoza-Rodríguez, I Hernández-Chico, B Gutiérrez-Soto, J M Navarro-Marí, J Gutiérrez-Fernández
{"title":"[Microbial etiology of bacterial chronic prostatitis: systematic review].","authors":"R Mendoza-Rodríguez,&nbsp;I Hernández-Chico,&nbsp;B Gutiérrez-Soto,&nbsp;J M Navarro-Marí,&nbsp;J Gutiérrez-Fernández","doi":"10.37201/req/099.2022","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The importance of Gram-positive microorganisms and atypical bacteria in chronic bacterial prostatitis (CBP) has recently been described. For this reason, this study analyzes the etiology of CBP, as well as the evolution of antibiotic resistance through a systematic review.</p><p><strong>Methods: </strong>A systematic review of studies obtained through the MEDLINE (PubMed) database, related to the etiology and antibiotic resistance profile of CBP, published up July 1, 2021.</p><p><strong>Results: </strong>The most frequent isolated microorganisms that we have found in publications are Enterococcus faecalis (46.90%), Staphylococcus spp. (22.30%), Escherichia coli (15.09%) and atypical bacteria (6.04%).</p><p><strong>Conclusions: </strong>CBP is undergoing and unprecedented change of paradigm. Gram-positive bacteria and atypical bacteria are the main pathogens involved in the aetiology of this entity. This forces us to rethink the therapeutic strategy used, since it is necessary to use antibiotics that assume the etiological change and the profile of antibiotic resistance described.</p>","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ae/8b/revespquimioter-36-144.PMC10066912.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola De Quimioterapia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.37201/req/099.2022","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 2

Abstract

Objective: The importance of Gram-positive microorganisms and atypical bacteria in chronic bacterial prostatitis (CBP) has recently been described. For this reason, this study analyzes the etiology of CBP, as well as the evolution of antibiotic resistance through a systematic review.

Methods: A systematic review of studies obtained through the MEDLINE (PubMed) database, related to the etiology and antibiotic resistance profile of CBP, published up July 1, 2021.

Results: The most frequent isolated microorganisms that we have found in publications are Enterococcus faecalis (46.90%), Staphylococcus spp. (22.30%), Escherichia coli (15.09%) and atypical bacteria (6.04%).

Conclusions: CBP is undergoing and unprecedented change of paradigm. Gram-positive bacteria and atypical bacteria are the main pathogens involved in the aetiology of this entity. This forces us to rethink the therapeutic strategy used, since it is necessary to use antibiotics that assume the etiological change and the profile of antibiotic resistance described.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
细菌性慢性前列腺炎的微生物病因学:系统综述。
目的:近年来研究革兰氏阳性微生物和非典型细菌在慢性细菌性前列腺炎(CBP)中的重要性。因此,本研究通过系统回顾分析CBP的病因,以及抗生素耐药性的演变。方法:系统回顾了通过MEDLINE (PubMed)数据库获得的有关CBP病因和抗生素耐药性的研究,发表于2021年7月1日。结果:在文献中分离到的最常见的微生物是粪肠球菌(46.90%)、葡萄球菌(22.30%)、大肠杆菌(15.09%)和非典型细菌(6.04%)。结论:海关海关正在经历前所未有的范式变革。革兰氏阳性细菌和非典型细菌是主要的病原体参与这个实体的病因学。这迫使我们重新思考所使用的治疗策略,因为有必要使用假定病原学变化和抗生素耐药性概况的抗生素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.90
自引率
10.50%
发文量
146
审稿时长
>12 weeks
期刊介绍: The official journal of the Sociedad Española de Quimioterapia (Spanish Society of Chemotherapy), publishes articles that further knowledge and advance the science and application of antimicrobial chemotherapy with antibiotics and antifungal, antiviral and antiprotozoal agents primarily in human medicine. Authors sign an exclusive license agreement, where authors have copyright but license exclusive rights in their article to the Publisher. All manuscripts are free open access. Revista Española de Quimioterapia includes the following sections: reviews, original articles, brierf reports, letters, and consensus documents.
期刊最新文献
[Chronic bacterial prostatitis with microbiological diagnosis: a report of two cases]. [Evaluation of Sysmex UF-5000 flow cytometer flag BACT-info for Gram discrimination in urinary tract infection]. [Gram staining of blood cultures from an oncologic patient]. [Increase in severe acute respiratory infections in children during the last phase of the COVID-19 pandemic]. [Moraxella spp. bacteremia in children attended in a hospital in southern Spain].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1